Loading clinical trials...
Loading clinical trials...
Protocole Evaluant Chez Des Patients Porteurs de Cancers Colorectaux Metastatiques l'Interet Des Determinants Genotypiques Pour l'Optimisation de l'Efficacite et de la Tolerance de la Chimiotherapie Par Irinotecan et 5-fluorouracile
Conditions
Interventions
irinotecan
5 fluorouracil
Locations
6
France
Department of Oncology, CHU
Grenoble, France
Department of Oncology, IPC
Grenoble, France
Department of Gastroenterology, CHLS
Pierre-Bénite, France
Department of Oncology - CHLS
Pierre-Bénite, France
Department of Oncology, ICL
Saint-Priest-en-Jarez, France
Institut Claudius Regaud
Toulouse, France
Start Date
June 1, 2005
Primary Completion Date
November 1, 2008
Completion Date
December 1, 2008
Last Updated
July 20, 2010
NCT06625775
NCT04657068
NCT06607458
NCT06820463
NCT07361003
NCT06792695
Lead Sponsor
Institut de Recherche Clinique sur les Cancers et le Sang
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions